Palisade Bio
PALI
Palisade Bio (PALI) news
Recent news
Second-generation Hyundai Palisade nears 300,000 units sold worldwide - Yonhap
The second-generation Hyundai Palisade is approaching a significant sales milestone, nearing 300,000 units sold worldwide since its launch. This performance underscores the model’s growing popularity in key markets, particularly in North America and South Korea. The Palisade’s success is attributed…
AInvest Wire · Sep 27, 2026Palisade Bio expands global phase 2B Ascentra-UC program with Health Canada CTA clearance
AInvest Wire · Sep 23, 2026Palisade Bio - First patient dosing targeted for Q1 2027; efficacy readout targeted for Q1 2028
AInvest Wire · Sep 22, 2026Palisade Bio receives FDA clearance of ind for Pali-2108 in Crohn’s disease, expanding phase 2 development across IBD
AInvest Wire · Sep 22, 2026Palisade Bio reports second quarter 2026 financial results and highlights continued advancement of Pali-2108 into Phase 2 development
AInvest Wire · Aug 10, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.